V. Lenhard

521 total citations
30 papers, 373 citations indexed

About

V. Lenhard is a scholar working on Immunology, Hematology and Nephrology. According to data from OpenAlex, V. Lenhard has authored 30 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Hematology and 7 papers in Nephrology. Recurrent topics in V. Lenhard's work include Blood groups and transfusion (8 papers), T-cell and B-cell Immunology (7 papers) and Renal Diseases and Glomerulopathies (6 papers). V. Lenhard is often cited by papers focused on Blood groups and transfusion (8 papers), T-cell and B-cell Immunology (7 papers) and Renal Diseases and Glomerulopathies (6 papers). V. Lenhard collaborates with scholars based in Germany, Thailand and Australia. V. Lenhard's co-authors include Elisabeth Fischer, R. Johannsen, Bernd Dörken, Erwin Schöpf, Gerhard E. Feurle, Gerhard Opelz, D. Roelcke, H. P. Geisen, E. Schleiermacher and H. P. Seelig and has published in prestigious journals such as Transplantation, Annual Review of Medicine and Pediatric Research.

In The Last Decade

V. Lenhard

28 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Lenhard Germany 9 104 92 67 67 60 30 373
W Schneider Germany 10 176 1.7× 56 0.6× 65 1.0× 18 0.3× 60 1.0× 43 421
Masanobu Morioka Japan 11 129 1.2× 47 0.5× 50 0.7× 53 0.8× 25 0.4× 64 329
J Gmür Switzerland 10 331 3.2× 135 1.5× 28 0.4× 25 0.4× 51 0.8× 26 494
D Samson United Kingdom 12 372 3.6× 50 0.5× 42 0.6× 20 0.3× 40 0.7× 23 560
Robert L. Wall United States 10 68 0.7× 49 0.5× 99 1.5× 57 0.9× 49 0.8× 18 402
M. Kerowgan Germany 10 200 1.9× 44 0.5× 50 0.7× 14 0.2× 53 0.9× 16 359
E. Koivunen Finland 14 252 2.4× 31 0.3× 25 0.4× 52 0.8× 89 1.5× 24 451
W Rybka United States 9 318 3.1× 93 1.0× 50 0.7× 23 0.3× 112 1.9× 14 489
K. W. Chan United States 10 262 2.5× 66 0.7× 43 0.6× 20 0.3× 35 0.6× 15 386
C. M. van Dalen Netherlands 10 294 2.8× 148 1.6× 46 0.7× 12 0.2× 30 0.5× 13 447

Countries citing papers authored by V. Lenhard

Since Specialization
Citations

This map shows the geographic impact of V. Lenhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Lenhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Lenhard more than expected).

Fields of papers citing papers by V. Lenhard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Lenhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Lenhard. The network helps show where V. Lenhard may publish in the future.

Co-authorship network of co-authors of V. Lenhard

This figure shows the co-authorship network connecting the top 25 collaborators of V. Lenhard. A scholar is included among the top collaborators of V. Lenhard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Lenhard. V. Lenhard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller, G. A., H. Bockhorn, V. Lenhard, et al.. (2008). Höhere Erfolgsraten bei der Nierentransplantation durch die HLA-DR-Typisierung: Eine retrospektive Analyse der Süddeutschen Arbeitsgemeinschaft für Nierentransplantation*. DMW - Deutsche Medizinische Wochenschrift. 105(12). 401–405.
2.
Seltsam, Axel, et al.. (2002). A weak blood group A phenotype caused by a new mutation at the ABO locus. Transfusion. 42(3). 294–301. 22 indexed citations
3.
Schmitz, Gerd, et al.. (2000). Characterization of the novel allele HLA‐B*4417: implications for bone marrow transplantation. Tissue Antigens. 56(5). 463–466. 11 indexed citations
4.
Lenhard, V., et al.. (1992). Human Monoclonal Antibodies for the Differentiation of Rh-D Categories. Transfusion Medicine and Hemotherapy. 19(1). 9–11. 6 indexed citations
5.
Ruder, H., et al.. (1990). Human leucocyte antigens in idiopathic nephrotic syndrome in children. Pediatric Nephrology. 4(5). 478–481. 12 indexed citations
6.
Rößler, Wolfgang, et al.. (1985). Effect of Allogeneic Blood Transfusions on the Growth of Two Different Tumours in the Rat. Urologia Internationalis. 40(4). 217–219. 7 indexed citations
7.
Lenhard, V., et al.. (1985). SUPPRESSION OF ANTIBODY RESPONSE AND PROLONGATION OF SKIN GRAFT SURVIVAL BY MULTIPLE BLOOD TRANSFUSIONS IN THE RAT. Transplantation. 39(4). 424–429. 9 indexed citations
8.
Ruder, H., Gerhard Opelz, V. Lenhard, Alexander Schäfer, & Volker Daniel. (1984). A rapid screening technique for lymphocytotoxic antibodies using tray-frozen lymphocytes. Cryobiology. 21(5). 480–485. 5 indexed citations
9.
Ruder, H., K Schärer, V. Lenhard, Anne‐Margret Wingen, & Gerhard Opelz. (1983). HLA phenotypes and idiopathic nephrotic syndrome in children.. PubMed. 19. 602–6. 7 indexed citations
10.
Bockhorn, H., V. Lenhard, K. Dreikorn, et al.. (1983). HLA-DR-MT matching improves graft survival rate in cadaver kidney transplantation. Journal of Molecular Medicine. 61(1). 17–23. 4 indexed citations
11.
Roelcke, D., et al.. (1982). A further subspecificity within human monoclonal anti-Pr cold agglutinins. Annals of Hematology. 45(2). 109–114. 3 indexed citations
12.
Lenhard, V., et al.. (1982). A «Spontaneous» Cold-Reactive IgM Antibody with AntiHLA- B8 Specificity in a Patient with Multiple Sclerosis. Immunobiology. 160(5). 382–391. 4 indexed citations
13.
Schmidt, W., et al.. (1981). Effects of Crude and Purified Human Chorionic Gonadotropin on Lymphocyte Response. Gynecologic and Obstetric Investigation. 12(3). 132–140. 4 indexed citations
14.
Müller‐Wiefel, D. E., et al.. (1980). HLA IN MINIMAL CHANGE NEPHROTIC SYNDROME(MC) AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSS). Pediatric Research. 14(8). 1003–1003. 2 indexed citations
15.
Merz, Wolfgang E., W. Schmidt, & V. Lenhard. (1979). Separation of the Gonadotropic Activity of Crude Choriogonadotropin from the Inhibitory Effect on Lymphocyte Transformation. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 360(2). 1433–1444. 7 indexed citations
16.
Schleiermacher, E., et al.. (1978). The HLA system and leprosy in Thailand. Human Genetics. 42(2). 201–213. 28 indexed citations
17.
Till, Gerd O., V. Lenhard, & Diethard Gemsa. (1978). Chemotactic Activity of Lectins in vitro. PubMed. 154(2). 173–185. 5 indexed citations
18.
Schleiermacher, E., et al.. (1978). HLA antigen, gene, and haplotype frequencies in Thailand. Human Genetics. 41(1). 73–87. 5 indexed citations
19.
Lenhard, V., H. P. Seelig, H. P. Geisen, & D. Roelcke. (1978). Identification of I/i, Pr1-3 and Gd antigens in the human kidney: possible relevance to hyperacute graft rejection induced by cold agglutinins.. PubMed. 33(2). 276–82. 27 indexed citations
20.
Netzel, B., Georg W. Bornkamm, V. Lenhard, Sonja W. Scholz, & H. Grosse‐Wilde. (1977). HLA-D Typing with Homozygous Lymphoblastoid Cell Lines. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 153(1). 85–89. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026